Gene: GFOD1
Official Full Name: Gfo/Idh/MocA-like oxidoreductase domain containing 1provided by HGNC
Gene Summary: Predicted to enable nucleotide binding activity and oxidoreductase activity. Predicted to be located in extracellular region. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO21772 | GFOD1 Knockout cell line (HeLa) | Human | GFOD1 | 1:3~1:6 | Negative | Online Inquiry |
KO21773 | GFOD1 Knockout cell line (HCT 116) | Human | GFOD1 | 1:2~1:4 | Negative | Online Inquiry |
KO21774 | GFOD1 Knockout cell line (HEK293) | Human | GFOD1 | 1:3~1:6 | Negative | Online Inquiry |
KO21775 | GFOD1 Knockout cell line (A549) | Human | GFOD1 | 1:3~1:4 | Negative | Online Inquiry |
GFOD1 Gene Knockout Cell Lines are advanced research tools designed to investigate the functional implications of the GFOD1 gene, known to play a significant role in glucose metabolism and cell signaling pathways. By utilizing CRISPR-Cas9 technology for precise gene editing, these cell lines effectively render the GFOD1 gene non-functional, allowing researchers to study the downstream effects of its loss on cellular behavior, metabolism, and disease states.
The primary function of GFOD1 Gene Knockout Cell Lines lies in their ability to simulate disease models pertinent to conditions such as metabolic disorders, cancer, and neurodegenerative diseases. Researchers can observe changes in cellular processes, including apoptosis, proliferation, and differentiation, thereby elucidating the biological pathways associated with GFOD1. This systemic understanding is critical for identifying novel therapeutic targets and drug discovery efforts.
In terms of scientific importance, GFOD1 deficiency has been linked to various disease phenotypes, making these knockout cell lines invaluable for both basic and applied research. Their application can extend beyond the laboratory, potentially influencing clinical approaches to treatment strategies and personalized medicine based on the patient-specific pathways influenced by GFOD1.
What sets our GFOD1 Gene Knockout Cell Lines apart from alternatives is the rigorous validation process they undergo, ensuring high specificity and efficiency of gene editing. These lines are further characterized for functionality, providing researchers with reliable models that enhance reproducibility in experiments.
For researchers and clinicians alike, the utility of GFOD1 Gene Knockout Cell Lines is highlighted in their ability to provide insights into cellular mechanisms that translate into valuable data for experimental designs. Their use can significantly accelerate research timelines and improve outcomes in translational studies.
With years of experience in producing high-quality biological products, our company is committed to supporting the scientific community with tools that advance understanding and foster innovations in the biomedical field. By choosing GFOD1 Gene Knockout Cell Lines, researchers gain access to precision models that drive impactful discoveries.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.